Pharmacokinetic Profile of Lesogaberan (AZD3355) in Healthy Subjects: A Novel GABA(B)-Receptor Agonist Reflux Inhibitor

Objective: The aim of this study was to evaluate the pharmacokinetic profile of lesogaberan in healthy subjects after single oral and intravenous administration of (14)C-labeled lesogaberan and non-(14)C-labeled lesogaberan. Study Design: This was an open-label, single-center, randomized, two-way cr...

Descripción completa

Detalles Bibliográficos
Autores principales: Niazi, Mohammad, Skrtic, Stanko, Ruth, Magnus, Holmberg, Ann A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2012
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3585951/
https://www.ncbi.nlm.nih.gov/pubmed/21410297
http://dx.doi.org/10.2165/11590310-000000000-00000

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3585951/
https://www.ncbi.nlm.nih.gov/pubmed/21410297
http://dx.doi.org/10.2165/11590310-000000000-00000

Ejemplares similares